MedPath

Sperimental, controlled, randomized single blind study. Sufentanil vs fentanyl in patientes with thoracotomy for pulmonary resection and videolaparoscopic surgery. - Sufentanil vs Fentanyl in thoracotomy

Conditions
Patientes with thoracotomy for pulmonary resection and videolaparoscopic surgery.
MedDRA version: 9.1Level: LLTClassification code 10062043Term: Lung operation
Registration Number
EUCTR2007-005544-24-IT
Lead Sponsor
AZIENDA OSPEDALIERA DI PADOVA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patientes with thoracotomy for pulmonary resection:
age 18-80 years old;
ASA classes: I,II,III;
surgery duration higher 2 hours;
epidural catheter beetween T3 and T8.
Patientes with videolaparoscopic surgery:
age 18-80 years old;
ASA classes: I,II,III.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patientes with thoracotomy for pulmonary resection:
- age< 18 years old and age>80years old,
- surgery duration inferior to 2 hours, - ASA class IV,
- blood loss > 0.5 liter,
- difficulties with epidural catheter,
- renal and liver failure
- heart failure NYHA III-IV
- psichiatric disorders
Patientes with videolaparoscopic surgery:
- age< 18 years old and age>80years old,
- surgery duration superior to 4 hours,
- renal and liver failure
- heart failure NYHA III-IV
- psichiatric disorders

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Efficacy and safety of sufentanil vs fentanyl during anesthesia in thoracotomy for pulmonary resection and in videolaparoscopic surgery.;Secondary Objective: To estimate if sufentanil is responsable of a better analgesia in post surgery time.;Primary end point(s):
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath